title: [Prostate cancer and androgen deprivation: benefits of psychological counseling].
abstract: Androgen deprivation is a therapeutic option for patients with prostate cancer, however with a range of side effects that negatively affects their physical and psychological condition. A multidisciplinary care program, ADAPP ("Androgenic deprivation in prostate cancer patients"), has been created with a special focus on managing these side effects. This article describes the intervention of the liaison psychiatry within this program, with care options ranging from psychological support to intensive psychotherapy to address patients' intrapsychic dynamics throughout this care program. Clinical cases are reported to illustrate the relevance and the necessity of this specialized counselling.
authors.affiliation: Service de psychiatrie de liaison et d'intervention de crise, Département de santé mentale et de psychiatrie, HUG, Genève 14. laura.frambati@hcuge.ch
authors.forename: L
authors.initials: L
authors.lastname: Frambati
authors.forename: K
authors.initials: K
authors.lastname: Weber
authors.forename: A
authors.initials: A
authors.lastname: Canuto
authors.forename: R
authors.initials: R
authors.lastname: Miralbell
authors.forename: T
authors.initials: T
authors.lastname: Zilli
authors.forename: C
authors.initials: C
authors.lastname: Pichard
authors.forename: C
authors.initials: C
authors.lastname: Joly
authors.forename: N
authors.initials: N
authors.lastname: Voison
authors.forename: J Flores Alves Dos
authors.initials: JF
authors.lastname: Santos
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000726:Androgen Antagonists / Q000008:administration & dosage* / Q000009:adverse effects; D003376:Counseling / Q000379:methods; D003863:Depression / Q000139:chemically induced / Q000517:prevention & control; D007172:Erectile Dysfunction / Q000139:chemically induced / Q000517:prevention & control; D005221:Fatigue / Q000139:chemically induced / Q000517:prevention & control; D006801:Humans; D033183:Interdisciplinary Communication; D007989:Libido / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D010024:Osteoporosis / Q000139:chemically induced / Q000517:prevention & control; D010348:Patient Care Team; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000628:therapy*; D011613:Psychotherapy; D007319:Sleep Initiation and Maintenance Disorders / Q000139:chemically induced / Q000517:prevention & control; D016896:Treatment Outcome
chemical_list: D000726:Androgen Antagonists